Literature DB >> 11714763

Cutting edge: histone acetylation and recombination at the TCR gamma locus follows IL-7 induction.

J Huang1, S K Durum, K Muegge.   

Abstract

IL-7 signaling is required for V(D)J recombination at the TCRgamma locus. We have recently reported that IL-7 controls chromatin accessibility for RAG-mediated cleavage. Inhibition of histone deacetylase substituted for the IL-7 signal, indicating a role for histone acetylation in altering chromatin accessibility. We found a greatly reduced histone 3 and histone 4 acetylation level in IL-7Ralpha(-/-) thymocytes in comparison with RAG(-/-) thymocytes or fetal thymocytes. Sterile transcripts, indicating an open chromatin configuration, were suppressed in IL-7Ralpha(-/-) and IL-7(-/-)RAG(-/-) thymocytes. Moreover, exogenously added IL-7 induced sterile transcripts from the TCRgamma constant region in cultured thymocytes from IL-7(-/-)RAG(-/-) mice. This induction correlated with increased histone acetylation at the J-promoter and C-enhancer regulatory elements at the TCRgamma locus. These results suggest that IL-7 regulates chromatin accessibility for V(D)J recombination by specifically altering histone acetylation within the TCRgamma locus.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11714763     DOI: 10.4049/jimmunol.167.11.6073

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

Review 1.  Progression of regulatory gene expression states in fetal and adult pro-T-cell development.

Authors:  Elizabeth-Sharon David-Fung; Mary A Yui; Marissa Morales; Hua Wang; Tom Taghon; Rochelle A Diamond; Ellen V Rothenberg
Journal:  Immunol Rev       Date:  2006-02       Impact factor: 12.988

Review 2.  Molecular mechanisms that control mouse and human TCR-alphabeta and TCR-gammadelta T cell development.

Authors:  Tom Taghon; Ellen V Rothenberg
Journal:  Semin Immunopathol       Date:  2008-10-17       Impact factor: 9.623

Review 3.  Transcriptional control of early T and B cell developmental choices.

Authors:  Ellen V Rothenberg
Journal:  Annu Rev Immunol       Date:  2014-01-22       Impact factor: 28.527

4.  Interleukin 15 controls the generation of the restricted T cell receptor repertoire of gamma delta intestinal intraepithelial lymphocytes.

Authors:  Hang Zhao; Hai Nguyen; Joonsoo Kang
Journal:  Nat Immunol       Date:  2005-11-06       Impact factor: 25.606

5.  Lsh, a modulator of CpG methylation, is crucial for normal histone methylation.

Authors:  Qingsheng Yan; Jiaqiang Huang; Tao Fan; Heming Zhu; Kathrin Muegge
Journal:  EMBO J       Date:  2003-10-01       Impact factor: 11.598

6.  Lsh, an epigenetic guardian of repetitive elements.

Authors:  Jiaqiang Huang; Tao Fan; Qingsheng Yan; Heming Zhu; Stephen Fox; Haleem J Issaq; Lionel Best; Lisa Gangi; David Munroe; Kathrin Muegge
Journal:  Nucleic Acids Res       Date:  2004-09-24       Impact factor: 16.971

Review 7.  Mechanics of T cell receptor gene rearrangement.

Authors:  Michael S Krangel
Journal:  Curr Opin Immunol       Date:  2009-04-09       Impact factor: 7.486

8.  Foxo1 and Foxp1 play opposing roles in regulating the differentiation and antitumor activity of TH9 cells programmed by IL-7.

Authors:  Enguang Bi; Xingzhe Ma; Yong Lu; Maojie Yang; Qiang Wang; Gang Xue; Jianfei Qian; Siqing Wang; Qing Yi
Journal:  Sci Signal       Date:  2017-10-10       Impact factor: 8.192

9.  Acetylation increases access of remodelling complexes to their nucleosome targets to enhance initiation of V(D)J recombination.

Authors:  Karl P Nightingale; Matthias Baumann; Anton Eberharter; Adamantios Mamais; Peter B Becker; Joan Boyes
Journal:  Nucleic Acids Res       Date:  2007-09-18       Impact factor: 16.971

10.  Reduced Function and Diversity of T Cell Repertoire and Distinct Clinical Course in Patients With IL7RA Mutation.

Authors:  Atar Lev; Amos J Simon; Ortal Barel; Eran Eyal; Efrat Glick-Saar; Omri Nayshool; Ohad Birk; Tali Stauber; Amit Hochberg; Arnon Broides; Shlomo Almashanu; Ayal Hendel; Yu Nee Lee; Raz Somech
Journal:  Front Immunol       Date:  2019-07-17       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.